Ghigo; Ezio

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ghigo; Ezio.The latest application filed is for "use of unacylated ghrelin, fragments and analogs thereof as antioxidant".

Company Profile

0.7.10

Ghigo; Ezio - Torino IT
Ghigo; Ezio - Turin IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use Of Unacylated Ghrelin, Fragments And Analogs Thereof As Antioxidant App 20160151458 - Brizzi; Maria Felice ; et al.	2016-06-02
Use Of Unacylated Ghrelin, Fragments And Analogs Thereof As Antioxidant App 20140378380 - Brizzi; Maria Felice ; et al.	2014-12-25
Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease Grant 8,476,408 - Brizzi , et al. July 2, 2	2013-07-02
Unacylated ghrelin as therapeutic agent in the treatment of metabolic disorders Grant 8,222,217 - Ghigo , et al. July 17, 2	2012-07-17
Methods for promoting growth and survival of insulin-secreting cells Grant 8,071,368 - Ghigo , et al. December 6, 2	2011-12-06
Unacylated Ghrelin And Analogs As Therapeutic Agents For Vascular Remodeling In Diabetic Patients And Treatment Of Cardiovascular Disease App 20110160121 - Brizzi; Maria Felice ; et al.	2011-06-30
Use of ghrelin and unacylated ghrelin compositions for treating insulin resistance Grant 7,825,090 - Ghigo , et al. November 2, 2	2010-11-02
Pharmaceutical Compositions Comprising Unacylated Ghrelin And Therapeutical Uses Thereof App 20100196330 - Ghigo; Ezio ; et al.	2010-08-05
Unacylated Ghrelin As Therapeutic Agent In The Treatment Of Metabolic Disorders App 20100168033 - Ghigo; Ezio ; et al.	2010-07-01
Unacylated Ghrelin And Analogs As Therapeutic Agents For Vascular Remodeling In Diabetic Patients And Treatment Of Cardiovascular Disease App 20100016226 - Brizzi; Maria ; et al.	2010-01-21
Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof Grant 7,485,620 - Ghigo , et al. February 3, 2	2009-02-03
Unacylated Ghrelin As Therapeutic Agent In The Treatment Of Metabolic Disorders App 20080312133 - Ghigo; Ezio ; et al.	2008-12-18
Use of Ghrelin and Unacylated Ghrelin Compositions in Insulin-Related Disease Conditions App 20080261872 - Ghigo; Ezio ; et al.	2008-10-23
Pharmaceutical Compositions Comprising Unacylated Ghrelin And Therapeutical Uses Thereof App 20080159991 - Ghigo; Ezio ; et al.	2008-07-03
Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof App 20050080007 - Ghigo, Ezio ; et al.	2005-04-14
Pharmaceutical composition for intranasal administration, comprising GH-releasing hormone, a cholinergic agonist and optionally a bile salt Grant 5,010,056 - Boghen , et al. April 23, 1	1991-04-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.